Trial intelligence / Profile preview

Lenstatin for Post-Vitrectomy Cataract

NCT02131194Completed

Sponsor
Lenstatin
Start
Jun 2014
Primary completion
Dec 2015
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by Lenstatin. Primary endpoint: Pentacam Nuclear Density Measurements at 6 months. Started Jun 2014; status: completed.

Beyond the preview

Go deeper on NCT02131194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02131194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call